Attention-deficit hyperactivity disorder and the stress response

被引:103
|
作者
King, JA [1 ]
Barkley, RA [1 ]
Barrett, S [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA
关键词
attention-deficit hyperactivity disorder; stress; hypothalamic-pituitary-adrenal axis; cortisol; development;
D O I
10.1016/S0006-3223(97)00507-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Attention-deficit hyperactivity disorder (ADHD) is a developmental disorder whose three main symptoms are impulsiveness, inattention, and hyperactivity. Researchers have proposed that the central deficit in ADHD is one of poor response inhibition. The present studies were designed to look at the functioning of the hypothalamic-pituitary-adrenal (HPA) axis in response to mental stress in aggressive ADHD subjects participating in a longitudinal study of various psychosocial treatments. Methods: Pretest and posttest morning salivary samples for cortisol determination were collected from subjects given a battery of tests. Results: The study shows that ADHD subjects who maintained their diagnosis otter the first year of the study had a blunted response to the stressor in comparison to those ADHD subjects who no longer retained the disorder 1 year later. Conclusions: The data suggest that an impaired response to stress may be a marker for the more developmentally persistent form of the disorder. Biol Psychiatry 1998;44: 72-74 (C) 1998 Society of Biological Psychiatry.
引用
收藏
页码:72 / 74
页数:3
相关论文
共 50 条
  • [31] A queueing model for Attention-Deficit/Hyperactivity Disorder
    Hlynka, M
    Mandziuk, L
    6TH WORLD MULTICONFERENCE ON SYSTEMICS, CYBERNETICS AND INFORMATICS, VOL IV, PROCEEDINGS: MOBILE/WIRELESS COMPUTING AND COMMUNICATION SYSTEMS I, 2002, : 243 - 248
  • [32] Pharmacologic treatment of attention-deficit hyperactivity disorder
    Donald E. Greydanus
    The Indian Journal of Pediatrics, 2005, 72 (11) : 953 - 960
  • [33] Attention-deficit/hyperactivity disorder and substance abuse
    Teran Prieto, Antonio
    MEDICINA-BUENOS AIRES, 2020, 80 : 76 - 79
  • [34] Rodent models of attention-deficit/hyperactivity disorder
    Sagvolden, T
    Russell, VA
    Aase, H
    Johansen, EB
    Farshbaf, M
    BIOLOGICAL PSYCHIATRY, 2005, 57 (11) : 1239 - 1247
  • [35] Attention-deficit hyperactivity disorder in adults with epilepsy
    Ashjazadeh, Nahid
    Sahraeian, Ali
    Sabzgolin, Iman
    Asadi-Pooya, Ali A.
    EPILEPSY & BEHAVIOR, 2019, 101
  • [36] Attention-Deficit/Hyperactivity Disorder and Substance Abuse
    Harstad, Elizabeth
    Levy, Sharon
    PEDIATRICS, 2014, 134 (01) : E293 - E301
  • [37] Attention-deficit/hyperactivity disorder during adulthood
    Magnin, E.
    Maurs, C.
    REVUE NEUROLOGIQUE, 2017, 173 (7-8) : 506 - 515
  • [38] Emerging drugs for attention-deficit/hyperactivity disorder
    Weisler, Richard H.
    EXPERT OPINION ON EMERGING DRUGS, 2007, 12 (03) : 423 - 434
  • [39] EEG in adults with Attention-Deficit/Hyperactivity Disorder
    Clarke, Adam R.
    Barry, Robert J.
    Heaven, Patrick C. L.
    McCarthy, Rory
    Selikowitz, Mark
    Byrne, Mitchell K.
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2008, 70 (03) : 176 - 183
  • [40] Atomoxetine treatment of attention-deficit/hyperactivity disorder
    Eiland, LS
    Guest, AL
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (01) : 86 - 90